(S)-3-[1-Methylpyrrolidin-2-yl]Pyridine, Analogues Thereof, Precursors Thereof, or its Derivatives, for the Use as a Pharmaceutical in Form of a Parenteral Administration and a Process for the Preparation of an Injectable Substance
The invention relates to a (S)-3-[1-Methylpyrrolidin-2-yl]pyridine analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a substance as a colloid of fine solid and/or liquid particles in a fluid. 1.According to the invention the substance is dispensed in form of a parenteral administration into a human and/or animal body..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 03. Juni Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HERRERA ARTURO SOLIS [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-06-03, Last update posted on www.tib.eu: 2023-06-05, Last updated: 2023-06-14 |
|---|
| Patentnummer: |
US2021161878 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011788984 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011788984 | ||
| 003 | DE-627 | ||
| 005 | 20230614164311.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210622s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA011788984 | ||
| 035 | |a (EPA)US2021161878 | ||
| 035 | |a (EPA)69375890 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HERRERA ARTURO SOLIS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a (S)-3-[1-Methylpyrrolidin-2-yl]Pyridine, Analogues Thereof, Precursors Thereof, or its Derivatives, for the Use as a Pharmaceutical in Form of a Parenteral Administration and a Process for the Preparation of an Injectable Substance |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-06-03, Last update posted on www.tib.eu: 2023-06-05, Last updated: 2023-06-14 | ||
| 520 | |a The invention relates to a (S)-3-[1-Methylpyrrolidin-2-yl]pyridine analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a substance as a colloid of fine solid and/or liquid particles in a fluid. 1.According to the invention the substance is dispensed in form of a parenteral administration into a human and/or animal body. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 03. Juni |
| 773 | 1 | 8 | |g year:2021 |g day:03 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/69375890/publication/US2021161878A1?q=US2021161878 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 03 |c 06 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 03 |c 06 | ||